ACCA · Question 09 · Corporation tax liabilities
Section A
BioGenix Ltd is a qualifying Small and Medium-sized Enterprise (SME) for Research and Development (R&D) purposes. During the year ended 31 March 2024, it incurred £100,000 of qualifying R&D revenue expenditure.
What is the total deduction BioGenix Ltd can claim against its trading profits for this expenditure?
Answer options:
£100,000
£130,000
£186,000
£230,000
32 questions · hints · full answers · grading